Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes

被引:0
|
作者
Yu, B [1 ]
Gauthier, L [1 ]
Hausmann, DHF [1 ]
Wucherpfennig, KW [1 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
关键词
autoimmunity; diabetes; MHC; autoantigen; antigen presentation;
D O I
10.1002/1521-4141(200009)30:9<2497::AID-IMMU2497>3.0.CO;2-J
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The major histocompatibility complex (MHC) is the most important susceptibility locus for type I diabetes in humans and NOD mice. NOD mice express a single MHC class II molecule (I-A(g7)) which carries a unique beta chain sequence. In humans, DQ alleles that encode DQ8 and DQ2 confer the highest risk for the disease. Soluble DQ8 and I-A(g7) were used to directly compare the binding specificity of these MHC molecules. Peptides from three islet antigens - insulin, GAD 65 and HSP 60 - bound to both CQ8 and I-A(g7). These peptides included epitopes that are immunodominant in NOD mice, namely insulin (9-23), GAD (206-220) and HSP 60 (441-460). All of these peptide sequences are highly conserved between the human and murine antigens. The binding specificity of DQ8 and I-A(g7) was similar, but not identical, since two peptides eluted from splenocytes of NOD mice did not bind to DQ8. DQ8 formed long-lived complexes with the majority of these peptides, indicating that DQ8 is not a poor peptide binder. These results demonstrate functional similarities between human and murine MHC class II molecules that confer susceptibility to type I diabetes.
引用
收藏
页码:2497 / 2506
页数:10
相关论文
共 50 条
  • [31] Prediction of peptides binding to MHC class I and II alleles by temporal motif mining
    Meydan, Cem
    Otu, Hasan H.
    Sezerman, Osman Ugur
    BMC BIOINFORMATICS, 2013, 14
  • [32] Computer prediction of the water-mediated binding of peptides to class I MHC molecules.
    Bui, HH
    Haworth, IS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U434 - U434
  • [33] Shared peptide binding motifs between human and murine Class I molecules: An analysis of the functional evolution of MHC polymorphism
    Sette, A
    Livingston, B
    Dzuris, J
    Sidney, J
    FASEB JOURNAL, 2001, 15 (05): : A1024 - A1024
  • [34] A continuous central motif of invariant chain peptides, CLIP, is essential for binding to various I-A MHC class II molecules
    Weenink, SM
    Milburn, PJ
    Gautam, AM
    INTERNATIONAL IMMUNOLOGY, 1997, 9 (02) : 317 - 325
  • [35] HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides
    Pezeshki, Abdul Mohammad
    Azar, Georges A.
    Mourad, Walid
    Routy, Jean-Pierre
    Boulassel, Mohamed-Rachid
    Denzin, Lisa K.
    Thibodeau, Jacques
    HUMAN IMMUNOLOGY, 2013, 74 (10) : 1280 - 1287
  • [36] SELF-PEPTIDES BOUND TO THE TYPE-I DIABETES-ASSOCIATED CLASS-II MHC MOLECULES HLA-DQ1 AND HLA-DQ8
    CHICZ, RM
    LANE, WS
    ROBINSON, RA
    TRUCCO, M
    STROMINGER, JL
    GORGA, JC
    INTERNATIONAL IMMUNOLOGY, 1994, 6 (11) : 1639 - 1649
  • [37] Structure-based prediction of binding peptides to MHC class I molecules: Application to a broad range of MHC alleles
    Schueler-Furman, O
    Altuvia, Y
    Sette, A
    Margalit, H
    PROTEIN SCIENCE, 2000, 9 (09) : 1838 - 1846
  • [38] Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules
    Astill, TP
    Ellis, RJ
    Arif, S
    Tree, TIM
    Peakman, M
    DIABETOLOGIA, 2003, 46 (04) : 496 - 503
  • [39] Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules
    T. P. Astill
    R. J. Ellis
    S. Arif
    T. I. M. Tree
    M. Peakman
    Diabetologia, 2003, 46 : 496 - 503
  • [40] AN EVOLUTIONARILY CONSERVED TARGET-CELL ANTIGEN ALONG WITH MHC CLASS-I MOLECULES INFLUENCES SUSCEPTIBILITY TO MURINE NK CELL-LYSIS
    KAPUR, R
    EVANS, DL
    HARRIS, DT
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 1995, 19 (04): : 347 - 355